8-KThe WireRoutine
Reg FD Disclosure
Filed Jan 8, 2026 · 5mo ago · Accession 0001193125-26-007077
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Jan 8, 2026
- Report date
- Jan 8, 2026
- Document
- acrv-20260108.htm
- Size
- 16.7 MB